ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

Avastin Regimen Bested Chemo Alone In Early Disease

January 31, 2003

In Brief: Recompetition Of Frederick Contract Flops, As Others Leave The Field To Litton-Bionetics

April 15, 1977

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Mysterious Group Urges Letters In Support Of Fisher, Calls For Investigation of NCI

April 22, 1994

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006

Advisors’ Report On Intramural Program To Recommend Restructuring

April 14, 1995